Topics

BioMarin to seek approval in US, EU for hemophilia A gene therapy

05:20 EDT 9 Jul 2019 | SmartBrief

BioMarin Pharmaceutical is slated to submit marketing applications for its gene therapy valoctocogene roxaparvovec, a treatme -More

Original Article: BioMarin to seek approval in US, EU for hemophilia A gene therapy

NEXT ARTICLE

More From BioPortfolio on "BioMarin to seek approval in US, EU for hemophilia A gene therapy"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...